Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Health In Tech, Inc. entered into Placement Agency Agreement with Craig-Hallum Capital Group LLC (effective 2026-03-25).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Craig-Hallum Capital Group LLC
- Effective
- 2026-03-25
Exact text from the filing
The Company also entered into a placement agency agreement (the “Placement Agency Agreement”) with Craig-Hallum Capital Group LLC, as the sole placement agent (the “Placement Agent”), dated March 25, 2026, pursuant to which the Placement Agent agreed to serve as the placement agent in connection with the PIPE in consideration for a cash placement fee and the reimbursement of certain out of pocket expenses, including those of its legal counsel.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Health In Tech, Inc. entered into Registration Rights Agreement with each Purchaser (effective 2026-03-25).
- Action
- entry
- Counterparty
- each Purchaser
- Effective
- 2026-03-25
Exact text from the filing
In connection with the Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with each Purchaser.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Health In Tech, Inc. entered into Purchase Agreement with certain accredited investors valued at approximately $7.0 million (effective 2026-03-25).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain accredited investors
- Value
- approximately $7.0 million
- Effective
- 2026-03-25
Exact text from the filing
On March 25, 2026, Health In Tech, Inc., a Nevada corporation (the “Company”), announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (each, a “Purchaser” and collectively, the “Purchasers”) relating to a private investment in public equity financing (the “PIPE”) for an aggregate of 5,600,000 shares of its common stock, par value $0.001 per share (the “Shares”).
View on SEC.gov